2013-2028 Report on Global Anti-tumor Drug Market by Player, Region, Type, Application and Sales Channel


Report ID : RC-51017 Category : Pharmaceuticals
Published Date : Oct-19 Pages : 119 Format : PDF
The global Anti-tumor Drug market was valued at $XX million in 2018, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.

This report provides detailed historical analysis of global market for Anti-tumor Drug from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Anti-tumor Drug market.

Leading players of Anti-tumor Drug including:
    Roche
    Novartis
    Celgene
    Bristol-Myers Squibb
    Amgen
    Johnson & Johnson
    Pfizer
    Takeda
    Eli Lilly
    AstraZeneca
    Astellas
    Merck & Co
    Sanofi
    Bayer
    Biogen Idec
    Eisai
    Teva
    Otsuka

Market split by Type, can be divided into:
    Cytotoxic Drugs
    Non-cytotoxic Drugs

Market split by Application, can be divided into:
    Alkylating Agents
    Anti-metabolism Drugs
    Platinum Antineoplastic Agents
    Anthracycline antitumor drugs
    Microtubule Stabilizer
    Endocrine Therapy Drugs

Market split by Sales Channel, can be divided into:
    Direct Channel
    Distribution Channel

Market segment by Region/Country including:
    North America (United States, Canada and Mexico)
    Europe (Germany, UK, France, Italy, Russia and Spain etc.)
    Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
    South America Brazil, Argentina, Colombia and Chile etc.)
    Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

Table of Contents

Chapter 1 Anti-tumor Drug Market Overview
    1.1 Anti-tumor Drug Definition
    1.2 Global Anti-tumor Drug Market Size Status and Outlook (2013-2028)
    1.3 Global Anti-tumor Drug Market Size Comparison by Region (2013-2028)
    1.4 Global Anti-tumor Drug Market Size Comparison by Type (2013-2028)
    1.5 Global Anti-tumor Drug Market Size Comparison by Application (2013-2028)
    1.6 Global Anti-tumor Drug Market Size Comparison by Sales Channel (2013-2028)
    1.7 Anti-tumor Drug Market Dynamics
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Anti-tumor Drug Market Segment Analysis by Player
    2.1 Global Anti-tumor Drug Sales and Market Share by Player (2016-2018)
    2.2 Global Anti-tumor Drug Revenue and Market Share by Player (2016-2018)
    2.3 Global Anti-tumor Drug Average Price by Player (2016-2018)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player
Chapter 3 Anti-tumor Drug Market Segment Analysis by Type
    3.1 Global Anti-tumor Drug Market by Type
        3.1.1 Cytotoxic Drugs
        3.1.2 Non-cytotoxic Drugs
    3.2 Global Anti-tumor Drug Sales and Market Share by Type (2013-2018)
    3.3 Global Anti-tumor Drug Revenue and Market Share by Type (2013-2018)
    3.4 Global Anti-tumor Drug Average Price by Type (2013-2018)
    3.5 Leading Players of Anti-tumor Drug by Type in 2018
    3.6 Conclusion of Segment by Type
Chapter 4 Anti-tumor Drug Market Segment Analysis by Application
    4.1 Global Anti-tumor Drug Market by Application
        4.1.1 Alkylating Agents
        4.1.2 Anti-metabolism Drugs
        4.1.3 Platinum Antineoplastic Agents
        4.1.4 Anthracycline antitumor drugs
        4.1.5 Microtubule Stabilizer
    4.2 Global Anti-tumor Drug Sales and Market Share by Application (2013-2018)
    4.3 Leading Consumers of Anti-tumor Drug by Application in 2018
    4.4 Conclusion of Segment by Application
Chapter 5 Anti-tumor Drug Market Segment Analysis by Sales Channel
    5.1 Global Anti-tumor Drug Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global Anti-tumor Drug Sales and Market Share by Sales Channel (2013-2018)
    5.3 Leading Distributors/Dealers of Anti-tumor Drug by Sales Channel in 2018
    5.4 Conclusion of Segment by Sales Channel
Chapter 6 Anti-tumor Drug Market Segment Analysis by Region
    6.1 Global Anti-tumor Drug Market Size and CAGR by Region (2013-2028)
    6.2 Global Anti-tumor Drug Sales and Market Share by Region (2013-2018)
    6.3 Global Anti-tumor Drug Revenue and Market Share by Region (2013-2018)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America Anti-tumor Drug Market Share by Type
        6.4.3 North America Anti-tumor Drug Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe Anti-tumor Drug Market Share by Type
        6.5.3 Europe Anti-tumor Drug Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific Anti-tumor Drug Market Share by Type
        6.6.3 Asia-Pacific Anti-tumor Drug Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America Anti-tumor Drug Market Share by Type
        6.7.3 South America Anti-tumor Drug Market Share by Application
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
        6.7.7 Chile
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa Anti-tumor Drug Market Share by Type
        6.8.3 Middle East & Africa Anti-tumor Drug Market Share by Application
        6.8.4 Egypt
        6.8.5 Saudi Arabia
        6.8.6 South Africa
        6.8.7 Nigeria
    6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Anti-tumor Drug Players
    7.1 Roche
        7.1.1 Company Snapshot
        7.1.2 Product/Business Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 Strategy and SWOT Analysis
    7.2 Novartis
    7.3 Celgene
    7.4 Bristol-Myers Squibb
    7.5 Amgen
    7.6 Johnson & Johnson
    7.7 Pfizer
    7.8 Takeda
    7.9 Eli Lilly
    7.10 AstraZeneca
    7.11 Astellas
    7.12 Merck & Co
    7.13 Sanofi
    7.14 Bayer
    7.15 Biogen Idec
    7.16 Eisai
    7.17 Teva
    7.18 Otsuka
Chapter 8 Upstream and Downstream Analysis of Anti-tumor Drug
    8.1 Industrial Chain of Anti-tumor Drug
    8.2 Upstream of Anti-tumor Drug
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of Anti-tumor Drug
        8.3.1 Leading Distributors/Dealers of Anti-tumor Drug
        8.3.2 Leading Consumers of Anti-tumor Drug
Chapter 9 Development Trend of Anti-tumor Drug (2019-2028)
    9.1 Global Anti-tumor Drug Market Size (Sales and Revenue) Forecast (2019-2028)
    9.2 Global Anti-tumor Drug Market Size and CAGR Forecast by Region (2019-2028)
    9.3 Global Anti-tumor Drug Market Size and CAGR Forecast by Type (2019-2028)
    9.4 Global Anti-tumor Drug Market Size and CAGR Forecast by Application (2019-2028)
    9.5 Global Anti-tumor Drug Market Size Forecast by Sales Channel (2019-2028)
Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification

Sidebar Menu